Source comparison
Post-Surgery BPC-157 Protocol: Dosing Comparison
Soft Tissue Repair (abdominal, minor reconstructive) 250–350mcg Twice daily (12-hour intervals) 14–21 days Subcutaneous, within 2–5 cm of incision Accelerated granulation tissue formation, reduced scar width, 15–25% shorter epithelialization time vs no interve
This comparison does not assign a generated winner or score.
- Soft Tissue Repair (abdominal, minor reconstructive)
- 250–350mcg
- Twice daily (12-hour intervals)
- 14–21 days
- Subcutaneous, within 2–5 cm of incision
- Accelerated granulation tissue formation, reduced scar width, 15–25% shorter epithelialization time vs no intervention
- Orthopedic Repair (tendon, ligament reconstruction)
- 350–500mcg
- 21–28 days
- Subcutaneous or IM, same limb/compartment as surgery
- Enhanced collagen type I deposition, 20–30% faster return to load-bearing in animal models, reduced adhesion formation
- Bone Fracture Fixation (surgical stabilization)
- 400–500mcg
- 28 days
- IM near fracture site or subcutaneous over affected bone
- Increased callus formation markers (ALP, osteocalcin), reduced time to radiographic union by 18–22% in preclinical studies
- Gastrointestinal Anastomosis (bowel resection, fistula repair)
- Subcutaneous, abdominal wall near surgical site
- Accelerated mucosal healing, reduced leak rate in animal models, counteracts NSAID-induced anastomotic breakdown